Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) was down 13% during trading on Monday . The company traded as low as GBX 1.70 ($0.02) and last traded at GBX 1.70 ($0.02). Approximately 80,437 shares changed hands during trading, a decline of 95% from the average daily volume of 1,541,478 shares. The stock had previously closed at GBX 1.96 ($0.02).
Cizzle Biotechnology Trading Down 1.5 %
The firm has a market cap of £7.59 million, a PE ratio of -2,686.30 and a beta of 0.38. The business’s 50-day simple moving average is GBX 1.81 and its 200 day simple moving average is GBX 1.85.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Are Penny Stocks a Good Fit for Your Portfolio?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is a Bond Market Holiday? How to Invest and Trade
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
